An investigation of combined SCLC and NSCLC demonstrated that the inactivation of TP53/RB1 function is related to the histogenesis of de novo combined SCLC/NSCLC and pulmonary adenocarcinoma with SCLC transformation after EGFR-TKI treatment. Here, TP53 is linked to non-small cell lung carcinoma.